Literature DB >> 2412651

Neurochemical studies on the existence, origin and characteristics of the serotonergic innervation of small pial vessels.

B Scatton, D Duverger, R L'Heureux, A Serrano, D Fage, J P Nowicki, E T MacKenzie.   

Abstract

Substantial concentrations of serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA), comparable to those found in brain tissue, were measured in the small pial vessels of the rat, rabbit and cat. Both rat and rabbit pial vessels exhibited a high affinity uptake process with kinetic parameters similar to those identified for the cerebral cortex. Labelled 5-HT, taken up by isolated rabbit pial vessels was released, in a calcium-dependent manner, by potassium-induced depolarization. Various pharmacological manipulations were carried out in the rat. Systemic administration of the 5-HT precursor, 5-hydroxytryptophan and the monoamine oxidase inhibitor, pargyline, significantly increased the concentration of 5-HT in the pial vessels; in contrast, two depleting agents (p-chloroamphetamine and reserpine) and the tryptophan hydroxylase inhibitor, p-chlorophenylalanine, all decreased the perivascular 5-HT levels. A serotonergic antagonist (methysergide) and a 5-HT receptor agonist (MK 212) respectively increased and decreased the concentrations of 5-HIAA in the pial vessels. These pharmacologically induced changes observed in pial vessels were not dissimilar from those noted for cortical tissue. Electrolytic lesions of the nuclei raphes medianus and/or dorsalis markedly decreased the levels of 5-HT and 5-HIAA in these small cerebral arterioles. Electrical stimulation of these nuclei decreased 5-HT although 5-HIAA concentrations tended to increase. A number of conclusions may be drawn from these studies. Thus, there is a serotonergic innervation of the cerebral circulation in several laboratory species which unequivocally originates in the raphé nuclei. Furthermore, these perivascular fibres possess synthetic, storage, release, inactivation and autoregulatory processes for 5-HT which, when further elucidated, may offer some rationale for the treatment of those cerebrovascular diseases in which this neurotransmitter and vasoactive agent is believed to be of pathological importance.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2412651     DOI: 10.1016/0006-8993(85)90997-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

Review 1.  5-HT3 receptor antagonists and migraine therapy.

Authors:  M D Ferrari
Journal:  J Neurol       Date:  1991       Impact factor: 4.849

2.  Mediation by 5-HT1D receptors of 5-hydroxytryptamine-induced contractions of rabbit middle and posterior cerebral arteries.

Authors:  V Deckert; D Pruneau; J L Elghozi
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

3.  Heterogeneous vasomotor responses of anatomically distinct feline cerebral arteries.

Authors:  E Hamel; L Edvinsson; E T MacKenzie
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

4.  Association of transcranial Doppler blood flow velocity slow waves with delayed cerebral ischemia in patients suffering from subarachnoid hemorrhage: a retrospective study.

Authors:  Vasilios E Papaioannou; Karol P Budohoski; Michal M Placek; Zofia Czosnyka; Peter Smielewski; Marek Czosnyka
Journal:  Intensive Care Med Exp       Date:  2021-03-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.